These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37852045)

  • 21. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
    de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
    Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.
    Cai Y; Fu P; Zhang X;
    Neurosci Lett; 2023 Apr; 802():137161. PubMed ID: 36858305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF Apo-E levels associate with cognitive decline and MRI changes.
    Toledo JB; Da X; Weiner MW; Wolk DA; Xie SX; Arnold SE; Davatzikos C; Shaw LM; Trojanowski JQ;
    Acta Neuropathol; 2014 May; 127(5):621-32. PubMed ID: 24385135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.
    Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C
    JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline.
    Lan G; Li A; Liu Z; Ma S; Guo T;
    Alzheimers Dement; 2023 Jun; 19(6):2408-2419. PubMed ID: 36478661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau.
    Lan G; Chen X; Yang J; Sun P; Cai Y; Li A; Zhu Y; Liu Z; Ma S; Guo T;
    Ann Neurol; 2024 May; 95(5):917-928. PubMed ID: 38356322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
    Ozlen H; Pichet Binette A; Köbe T; Meyer PF; Gonneaud J; St-Onge F; Provost K; Soucy JP; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
    JAMA Neurol; 2022 Oct; 79(10):1025-1035. PubMed ID: 35994280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
    Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M
    Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.
    Luo X; Qiu T; Jia Y; Huang P; Xu X; Yu X; Shen Z; Jiaerken Y; Guan X; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Oct; 11(5):1290-1301. PubMed ID: 27714554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau.
    Butt OH; Meeker KL; Wisch JK; Schindler SE; Fagan AM; Benzinger TLS; Cruchaga C; Holtzman DM; Morris JC; Ances BM
    Alzheimers Dement; 2022 Jan; 18(1):116-126. PubMed ID: 34002449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.
    Zenuni H; Bovenzi R; Bissacco J; Grillo P; Simonetta C; Mascioli D; Pieri M; Bernardini S; Sancesario GM; Stefani A; Mercuri NB; Schirinzi T
    Neurobiol Aging; 2023 Nov; 131():24-28. PubMed ID: 37572524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease.
    Petersen KK; Ezzati A; Lipton RB; Gordon BA; Hassenstab J; Morris JC; Grober E
    J Prev Alzheimers Dis; 2023; 10(1):112-119. PubMed ID: 36641615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer's disease.
    Han SW; Lee SH; Kim JH; Lee JJ; Park YH; Kim S; Nho K; Sohn JH
    Front Aging Neurosci; 2024; 16():1411466. PubMed ID: 39114318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults.
    Sible IJ; Nation DA;
    Neurology; 2022 Jun; 98(24):e2446-e2453. PubMed ID: 35418462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.
    Benitez BA; Karch CM; Cai Y; Jin SC; Cooper B; Carrell D; Bertelsen S; Chibnik L; Schneider JA; Bennett DA; ; ; Fagan AM; Holtzman D; Morris JC; Goate AM; Cruchaga C
    PLoS Genet; 2013; 9(8):e1003685. PubMed ID: 23990795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of CSF GAP-43 and
    Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE-ε4 modulates the association among plasma Aβ
    Shi D; Xie S; Li A; Wang Q; Guo H; Han Y; Xu H; Gan WB; Zhang L; Guo T;
    Transl Psychiatry; 2022 Mar; 12(1):128. PubMed ID: 35351867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.